Mubadala looks to boost investment in medical technology and life sciences – The National

Mubadala looks to boost investment in medical technology and life sciences – The National

Mubadala looks to boost investment in medical technology and life sciences. The company is pivoting to the technology industry as it repositions its portfolio of assets. Mubadala Investment Company, Abu Dhabi's strategic investment arm, is looking to "significantly" increase its investments in life sciences and medical technology sector, its group chief executive said.. "We do that domestically, in terms of how we invest in [healthcare] infrastructure," Mr Al Mubarak said.. "I'm all in when it comes to investing in tech space but double click on med-tech and double click on life sciences, an incredibly exciting area.". As part of the Mubadala's domestic expansion, the company's healthcare investment subsidiary bought Abu Dhabi-based Amana Healthcare last month.. Amana was Mubadala Healthcare's first investment in a UAE health services company.. The spread of the coronavirus has so far claimed more than 1,000 lives and infected more than 40,000 people.. Sars killed 774 people and infected about 8,100 people in 26 countries within eight months, the World Health Organisation figures said.. China's economy, which decelerated last year on the back of its tariff war with the US, is expected to slide further in 2020.. Last week the US Federal Reserve said the coronavirus presents